Procter & Gamble adds Wildberry flavor to Prilosec

September 20, 2012 by Mae Anderson
This undated product image provided by Procter & Gamble shows wildberry flavored Prilosec OTC, the company's over-the-counter heartburn medication. P&G executives admit that adding flavor to a pill you don't even chew might not seem like an obvious move, but it is aimed at capturing more consumers as competition grows in the so-called proton pump inhibitor category. Wildberry Prilosec OTC will begin shipping to retailers Thursday, Sept. 20, 2012, and will be on store shelves beginning in October. (AP Photo/Procter & Gamble)

(AP)—Procter & Gamble is adding a blast of fruit flavor to a pill that you swallow whole—a first for the world's largest consumer products maker.

In the biggest change to heartburn medication Prilosec since it became an over-the-counter drug in 2003, Procter & Gamble is adding a berry flavor to the pill—even though the pill meant to be is swallowed, not chewed.

It's a marketing gimmick more in line with the grocery aisles than the more staid medicine aisle and helps the pill compete more directly with flavored traditional antacids like Tums.

P&G says the pills are coated with ingredients that give off a cooling sensation as soon as you put it in your mouth. And the wild berry flavor lasts for up to five minutes afterward in your mouth. The flavoring was derived from technology from P&G's Vick's segment.

P&G executives acknowledge that adding flavor to a pill you don't even chew might not seem like an obvious move, but it is aimed at capturing more consumers as competition grows among the drugs known as proton pump inhibitors. The heartburn market is changing, as fewer consumers use antacids (like Tums or Pepto-Bismol), that neutralize existing acid, and more turn to medicines that block production of acid over time, like Prilosec and Zantac.

"Flavor, for many people seems surprising," said Patrick Lockwood-Taylor, vice president, general manager of North America Personal Health Care for Procter & Gamble. "But there are a lot of people who say, 'Look, if I've got something that is functional, I want something extra.' That's what this flavor gives them."

Cincinnati-based P&G says it is adding the flavor as a way to reach what it calls "experiential" consumers—the 30 percent or so of the 50 million frequent heartburn sufferers in the U.S. that crave new flavors and sensations and will always pick up something new on store shelves.

Procter & Gamble is hoping to capture more of the market of people switching from antacids to proton-pump inhibitors. PPIs are heavily promoted and a fast-growing category.

Prilosec, first introduced in 1989, has about a 47.6 percent share of the U.S. PPI market, according to research firm Euromonitor International, and is by far the biggest name in the growing category. Lockwood-Taylor said the aim is to keep that market share as the category itself grows. Store brands are second in the category and Novartis AG's Prevacid, which was introduced in 1995 and became over-the-counter 2009, is third.

In the U.S., sales of proton pump inhibitors rose about 1 percent to $965.7 million in 2011, while sales of antacids fell 2 percent to $695.8 million, according to Euromonitor.

Wildberry Prilosec OTC began shipping to retailers this week and will be on store shelves beginning in October.

Explore further: P&G to add latches to make detergent packs safer

shares

Related Stories

P&G to add latches to make detergent packs safer

May 25, 2012
(AP) -- Procter & Gamble says it will change the design of packaging for its miniature laundry detergent product to deter children from eating the brightly colored packets that look like candy.

Recommended for you

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.